Mouth Cancer (Oral Cancer) Supportive Care Protocol

Oncology/ENTLimited Evidence
5
supplements
2
Primary
3
Supporting
1
Grade A
38
Studies

Primary Stack

Core supplements with strongest evidence
10-30g daily during treatment

May help reduce mucositis severity from radiation/chemotherapy

10 studies600 participants
2000-4000 IU daily

Supports immune function; deficiency common in cancer patients

6 studies300 participants

Supporting Stack

Additional supplements for enhanced results
1.2-1.5g/kg/day total protein

Critical for maintaining nutrition when eating is difficult

12 studies800 participants
2-3g EPA+DHA daily

Anti-inflammatory; supports weight maintenance

6 studies300 participants
15-30mg daily

Supports wound healing and may help with taste changes

4 studies200 participants

How This Protocol Works

Simple Explanation

Mouth cancer (oral cancer) includes cancers of the lips, tongue, cheeks, floor of mouth, hard palate, and gums. Most are squamous cell carcinomas.

RISK FACTORS:

•Tobacco use (cigarettes, cigars, chewing tobacco)
•Heavy alcohol use
•HPV infection (especially HPV-16)
•Sun exposure (lip cancer)
•Poor oral hygiene
•Weakened immune system
•Betel nut chewing

WARNING SIGNS:

•Sore in mouth that doesn't heal (>2 weeks)
•Red or white patch in mouth
•Lump or thickening
•Difficulty chewing or swallowing
•Numbness in tongue or mouth
•Jaw swelling or stiffness
•Persistent sore throat
•Loose teeth with no dental reason

CRITICAL: Mouth cancer requires specialized oncological care. This protocol is SUPPORTIVE ONLY.

TREATMENT:

•Surgery (primary treatment for most)
•Radiation therapy
•Chemotherapy
•Targeted therapy
•Reconstructive surgery

TREATMENT CHALLENGES:

•Mucositis (painful mouth sores)
•Difficulty eating and swallowing
•Dry mouth (xerostomia)
•Taste changes
•Speech difficulties
•Weight loss

* Glutamine may help reduce mucositis.

* Nutrition is challenging but critical.

* Discuss all supplements with oncology team.

Expected timeline: Treatment duration and recovery depend on stage and treatment type. Mucositis typically peaks during treatment and improves afterward.

Clinical Perspective

Oral Cancer: Squamous cell carcinoma most common. Risk factors: tobacco, alcohol (synergistic), HPV (particularly oropharynx, now most common cause of oropharyngeal cancer). Staging: TNM. Treatment: surgery and/or radiation +/- chemotherapy based on stage/site.

Supportive care challenges: Mucositis, dysphagia, xerostomia, taste changes, malnutrition. Glutamine may reduce mucositis severity. Protein supplementation essential - PEG tube often needed. Discuss ALL supplements with oncology team - timing around treatment important. HPV-positive oropharyngeal has better prognosis.

* Glutamine (B-grade): Mucositis. Meta-analysis: (PMID: 22089180). 10-30g daily during treatment.

* Vitamin D (C-grade): Immune support. Review: (PMID: 28750270). 2000-4000 IU daily.

* Protein (A-grade): Nutrition. Guidelines: (PMID: 28698222). 1.2-1.5g/kg/day.

* Omega-3 (C-grade): Weight maintenance. Review: (PMID: 27840029). 2-3g EPA+DHA daily.

* Zinc (C-grade): Taste/healing. Review: (PMID: 26845419). 15-30mg daily.

Protocol notes: Screening: oral exam; suspicious lesions need biopsy. HPV testing: important for prognosis and potentially treatment decisions. Surgery: may require reconstruction (flaps). Radiation: intensity-modulated (IMRT) to spare tissue. Mucositis: good oral care, glutamine, pain management. PEG tube: consider prophylactically for significant dysphagia expected. Xerostomia: may be permanent; artificial saliva, pilocarpine. Dental: evaluation and treatment before radiation. Smoking cessation: critical. Rehabilitation: speech therapy, swallowing therapy, dental rehabilitation.